58 results
Page 2 of 3
DEFA14A
sacsig l8059
27 Apr 22
Additional proxy soliciting materials
4:07pm
8-K
EX-10.1
wlmar3ytd7 chfwf
16 Aug 21
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
4:41pm
8-K
EX-1.1
lz7gdt l9p3i
6 May 21
Entry into a Material Definitive Agreement
5:10pm
DEFA14A
y1yce ldpn
26 Apr 21
Additional proxy soliciting materials
6:15am
DEF 14A
suv2jvt a5habcit
26 Apr 21
Definitive proxy
6:05am
10-K
lre66qst
23 Mar 21
Annual report
4:21pm
424B4
23se5q0vo9y5fdmifq6
13 Nov 20
Prospectus supplement with pricing info
5:21pm
DRS
lep9 zaeggu06qifr
20 Jul 20
Draft registration statement
12:00am
10-Q
g6uuop1btrzy uq4
20 May 20
Quarterly report
4:31pm
8-K
EX-3.2
lp06rczohyeaxn
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm